{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:49:38Z","timestamp":1770972578738,"version":"3.50.1"},"reference-count":16,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2014]]},"DOI":"10.7883\/yoken.67.44","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T22:57:57Z","timestamp":1390345077000},"page":"44-46","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology of Extended-Spectrum ^|^beta;-Lactamase, AmpC, and Carbapenemase Production in Proteus mirabilis"],"prefix":"10.7883","volume":"67","author":[{"given":"Priya","family":"Datta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdish","family":"Chander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Pagani, L., Migliavacca, R., Pallecchi, L., et al. (2002): Emerging extended-spectrum β-lactamases in Proteus mirabilis<\/i>. J. Clin. Microbiol., 40, 1549–1552."},{"key":"2","unstructured":"2. Tenover, F.C., Emery, S.L., Spiegel, C.A., et al. (2009): Identification of plasmid-mediated Amp-C β-lactamases in Escherichia coli<\/i>, Klebsiella<\/i> spp., and Proteus<\/i> species can potentially improve reporting of cephalosporin susceptibility testing results. J. Clin. Microbiol., 47, 294–299."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tibbetts, R., Frye, J.G., Marschall, J., et al. (2008): Detection of KPC-2 in a clinical isolate of Proteus mirabilis<\/i> and first reported description of carbapenemase resistance caused by a KPC β-lactamases in Proteus mirabilis<\/i>. J. Clin. Microbiol., 46, 3080–3083.","DOI":"10.1128\/JCM.00979-08"},{"key":"4","unstructured":"4. Clinical and Laboratory Standards Institute (CLSI) (2011): Performance standards for antimicrobial susceptibility testing: 21st informational supplement M100-S21. CLSI, Wayne, Pa, USA."},{"key":"5","unstructured":"5. Kenneth, S.T. (2010): Extended-spectrum β-lactamases, AmpC, and carbapenemase issues. J. Clin. Microbiol., 48, 1019–1025."},{"key":"6","unstructured":"6. Gary, D.O. (2010): Carbapenemases. A brief review for pediatric infectious disease specialists. Pediatr. Infect. Dis. J., 29, 68–70."},{"key":"7","unstructured":"7. Collee, J.G., Miles, R.S. and Watt, B. (1996): Tests for the identification of bacteria. p. 151–179. In<\/i> Collee, J.G., Fraser, A.G., Marmion, B.P., et al. (eds), Mackie & MacCartney Practical Medical Microbiology. 14th ed. Churchill Livingstone, London."},{"key":"8","unstructured":"8. Black, J.A., Moland, E.S. and Thomson, K.S. (2005): AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae<\/i> lacking chromosomal AmpC β-lactamases. J. Clin. Microbiol., 43, 3110–3113."},{"key":"9","unstructured":"9. Jacoby, G.A. (2009): AmpC β-lactamases. Clin. Microbiol. Rev., 22, 161–182."},{"key":"10","unstructured":"10. Rudresh, S.M. and Nagarathnamma, T. (2011): Extended spectrum β-lactamase producing Enterobacteriaceae<\/i> & antibiotic co-resistance. Indian J. Med. Res., 133, 116–118."},{"key":"11","unstructured":"11. Khan, M.K.R., Thukral, S.S. and Gaind, R. (2008): Evaluation of a modified double-disc synergy test for detection of extended spectrum β-lactamases in Amp C β-lactamase-producing Proteus mirabilis<\/i>. Indian J. Med. Microbiol., 26, 58–61."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Thomson, K.S. (2001): Controversies about extended-spectrum and AmpC beta-lactamases. Emerg. Infect. Dis., 7, 333–336.","DOI":"10.3201\/eid0702.010238"},{"key":"13","unstructured":"13. Munier, G.K., Johnson, C.L., Snyder, J.W., et al. (2010): Positive extended-spectrum-β-lactamase (ESBL) screening results may be due to AmpC-lactamases more often than to ESBLs. J. Clin. Microbiol., 48, 673–674."},{"key":"14","unstructured":"14. Gupta, E., Mohanty, S., Sood, S., et al. (2006): Emerging resistance to carbapenem in a tertiary care hospital in North India. Indian J. Med. Res., 124, 95–98."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Prakash, S. (2006): Carbapenem sensitivity profile amongst bacterial isolates from clinical specimens in Kanpur city. Indian J. Crit. Care Med., 10, 250–253.","DOI":"10.4103\/0972-5229.29844"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gupta, N., Limbago, B.M., Patel, J.B., et al. (2011): Carbapenem-resistant Enterobacteriaceae<\/i>; epidemiology and prevention. Clin. Infect. Dis., 53, 60–67.","DOI":"10.1093\/cid\/cir202"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T21:59:14Z","timestamp":1621547954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/67\/1\/67_44\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.67.44","relation":{},"ISSN":["1344-6304"],"issn-type":[{"value":"1344-6304","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}